Premium

Select Committee Highlights Dangers of U.S. Pharma Partnering With Commie China

Xiao Yijiu/Xinhua via AP

In China, the genocidal, America-hating government requires all companies to host Communist cells and all “private” businesses to collaborate with the military. Yet American pharmaceutical companies keep collaborating with and investing in Chinese companies and operations.

The Select Committee on China posted about this June 2, as you can see below, while promoting the Biotech Investment National Security Act. “The Chinese Communist Party is an antagonist, not an ally, to American pharmaceutical production, manufacturing, and national security,” the committee emphasized. “This legislation will subject American investment in Chinese biotechnology to the review requirements of the Comprehensive Outbound Investment National Security (COINS) Act. When Pfizer and Bristol Myers partner with Chinese biotech companies, their deals imperil the future of American drug innovation. We must not allow American investment, expertise, and technology to offshore our biotech industry.”

Now, regardless of how effective the legislation would be — and given it is bipartisan, quite possibly it wouldn’t be — I want to focus on the underlying issue. Let's look at a couple examples from the COVID-19 era to illustrate why U.S. Big Pharma shouldn't invest in China, where "civil-military fusion" means there's no real separation between the Chinese Communist Party (CCP) and any medical companies.

The most obvious one, and very relevant to discussions of biotechnology, is the COVID-19 virus itself.In May 2024, while testifying before Congress, National Institutes of Health (NIH) Principal Deputy Director Lawrence Tabak admitted that U.S. taxpayer money funded dangerous gain-of-function research at the Wuhan Institute of Virology in China leading up to the lab leak that launched the COVID-19 pandemic. In this case, it was the U.S. government rather than a pharma company that helped create a medical crisis, but the effects of American money combined with CCP unscrupulousness  are always negative.

Read Also: Why Does Congress Want Us to Lose to the Terrorist Iranian Regime?

Here's an example involving an American pharma company. In mid-2020, as CCP lockdowns tightened with an economically destructive, extraordinarily tyrannical, and medically disastrous hand of iron across China, Johnson & Johnson was backing the CCP.  Alex Kopitsas, head of human resources for Johnson & Johnson China, gushed to CCP state propaganda outlet Global Times, "China is a critical market in Johnson & Johnson's global portfolio. It is not only our No1 growth engine but is also evolving to become a global hub for innovation." 

As the CCP government kept over a billion people imprisoned, censored, and harassed constantly in miserably aggressive lockdowns, Johnson & Johnson raved about the wonders of operating in China. In other words, in exchange for the slave labor and fewer safety rules that China offers, Johnson & Johnson lied for and pandered to the government responsible for a global medical catastrophe. A company that produced a vaccine supposedly countering the virus was complicit in covering up that virus's development, leak, and true nature.

The Select Committee on China right now is particularly worried about "Bristol Myers Squibb’s recently announced $15 billion deal with China’s Hengrui Pharma that also transfers intellectual property to China." The CCP is America's number one enemy, and it weaponizes medical research and medications against us just as they weaponize everything else. No American company should be allowed to operate in China and host CCP cells, but especially not pharmaceutical companies.

Recommended

Trending on PJ Media Videos

Advertisement
Advertisement